Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Newsome, Philip Noel, Fox, Richard, King, Andrew L · The Lancet Gastroenterology & Hepatology · 2018